Neuroproteomics in stem cell differentiation

Proteomics - Clinical Applications

Volumn 1, Issue 11, 2007, Pages 1513-1523

  Beyer, Susanne ^a   Mix, Eilhard ^a   Hoffrogge, Raimund ^b   Lünser, Katja ^a   Völker, Uwe ^c   Rolfs, Arndt ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Neural progenitor cell (NPC); Neural stem cell (NSC); Neuronal differentiation; Neuroproteomics; Proteome profiling

Indexed keywords

CYCLINE; ELONGATION FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LIPOCORTIN 5; MYOSIN LIGHT CHAIN; NEUROTROPHIC FACTOR; PEROXIREDOXIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEOME;

ANIMAL CELL; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GENE REARRANGEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESENCEPHALON; NEURAL STEM CELL; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; RAT; REVIEW; STRIATE CORTEX; TIME; TWO DIMENSIONAL ELECTROPHORESIS;

RATTUS;

EID: 38449103750     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200700324     Document Type: Review

References (77)

1. Goldman, S., Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol. 2005, 23, 862-871.
2. Lindvall, O., Kokaia, Z., Stem cells for the treatment of neurological disorders. Nature 2006, 441, 1094-1096.
3. Martino, G., Pluchino, S., The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 2006, 7, 395-406.
4. Kinoshita, Y., Uo, T., Jayadev, S., Garden, G. A. et al., Potential applications and limitations of proteomics in the study of neurological disease. Arch. Neurol. 2006, 63, 1692-1696.
5. Maurer, M. H., Feldmann, R. E., Jr., Futterer, C. D., Kuschinsky, W., The proteome of neural stem cells from adult rat hippocampus. Proteome Sci. 2003, 1, 4.
6. Maurer, M. H., Feldmann, R. E., Jr., Futterer, C. D., Butlin, J. et al., Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus. Neurochem. Res. 2004, 29, 1129-1144.
7. Hoffrogge, R., Mikkat, S., Scharf, C., Beyer, S. et al., 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006, 6, 1833-1847.
8. Hoffrogge, R., Beyer, S., Völker, U., Uhrmacher, A. et al., 2-DE proteomic profiling of neuronal stem cells. Neurodegener. Dis. 2006, 3, 112-122.
9. Hoffrogge, R., Beyer, S., Hubner, R., Mikkat, S. et al., 2-DE profiling of GDNF overexpression-related proteome changes in differentiating ST14A rat progenitor cells. Proteomics 2007, 7, 33-46.
10. Schwarz, J., Schwarz, S. C., Storch, A., Developmental perspectives on human midbrain-derived neural stem cells. Neurodegener. Dis. 2006, 3, 45-49.
11. Lindvall, O., Bjoerklund, A., Cell therapy in Parkinson's disease. NeuroRx 2004, 1, 382-393.
12. Pollock, K., Stroemer, P., Patel, S., Stevanato, L. et al., A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol. 2006, 199, 143-155.
13. Josephson, R., Ording, C. J., Liu, Y., Shin, S. et al., Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells 2007, 25, 437-446.
14. Guo, X., Ying, W., Wan, J., Hu, Z. et al., Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis 2001, 22, 3067-3075.
15. Hashimoto, R., Nakamura, Y., Imamura, K., Nakadate, K. et al., Visual stimulation-induced phosphorylation of neurofilament-L in the visual cortex of dark-reared rats. Eur. J. Neurosci. 2001, 14, 1237-1245.
16. Pearce, A., Svendsen, C. N., Characterisation of stem cell expression using two-dimensional electrophoresis. Electrophoresis 1999, 20, 969-970.
17. Wang, D., Gao, L., Proteomic analysis of neural differentiation of mouse embryonic stem cells. Proteomics 2005, 5, 4414-4426.
18. Battersby, A., Jones, R. D., Lilley, K. S., McFarlane, R. J. et al., Comparative proteomic analysis reveals differential expression of Hsp25 following the directed differentiation of mouse embryonic stem cells. Biochim. Biophys. Acta 2007, 1773, 147-156.
19. Morrison, R. S., Kinoshita, Y., Johnson, M. D., Uo, T. et al., Proteomic analysis in the neurosciences. Mol. Cell. Proteomics 2002, 1, 553-560.
20. Lubec, G., Krapfenbauer, K., Fountoulakis, M., Proteomics in brain research: Potentials and limitations. Prog. Neurobiol. 2003, 69, 193-211.
21. Baharvand, H., Fathi, A., Van Hoof, D., Salekdeh, G. H., Trends in stem cell proteomics. Stem Cells 2007, 25, 1888-1903.
22. Andrews, P. W., Matin, M. M., Bahrami, A. R., Damjanov, I. et al., Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: Opposite sides of the same coin. Biochem. Soc. Trans. 2005, 33, 1526-1530.
23. Loring, J. F., Rao, M. S., Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 2006, 24, 145-150.
24. Zenzmaier, C., Kollroser, M., Gesslbauer, B., Jandrositz, A. et al., Preliminary 2-D chromatographic investigation of the human stem cell proteome. Biochem. Biophys. Res. Commun. 2003, 310, 483-490.
25. Zenzmaier, C., Gesslbauer, B., Grobuschek, N., Jandrositz, A. et al., Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem. Biophys. Res. Commun. 2005, 328, 966-972.
26. Baharvand, H., Hajheidari, M., Zonouzi, R., Ashtiani, S. K. et al., Comparative proteomic analysis of mouse embryonic stem cells and neonatal-derived cardiomyocytes. Biochem. Biophys. Res. Commun. 2006, 349, 1041-1049.
27. Van Hoof, D., Passier, R., Ward-Van Oostwaard, D., Pinkse, M. W. et al., A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 2006, 5, 1261-1273.
28. Schrattenholz, A., Wozny, W., Klemm, M., Schroer, K. et al., Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model. J. Neurol. Sci. 2005, 229-230, 261-267.
29. Tibes, R., Qiu, Y., Lu, Y., Hennessy, B. et al., Reverse phase protein array: Validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 2006, 5, 2512-2521.
30. Yin, X., Mayr, M., Xiao, Q., Wang, W. et al., Proteomic analysis reveals higher demand for antioxidant protection in embryonic stem cell-derived smooth muscle cells. Proteomics 2006, 6, 6437-6446.
31. Behre, G., Reddy, V. A., Tenen, D. G., Hiddemann, W. et al., Proteomic analysis of transcription factor interactions in myeloid stem cell development and leukaemia. Expert Opin. Ther. Targets 2002, 6, 491-495.
32. Ota, J., Yamashita, Y., Okawa, K., Kisanuki, H. et al., Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders. Oncogene 2003, 22, 5720-5728.
33. Tao, W., Wang, M., Voss, E. D., Cocklin, R. R. et al., Comparative proteomic analysis of human CD34+ stem/progenitor cells and mature CD15+ myeloid cells. Stem Cells 2004, 22, 1003-1014.
34. Evans, C. A., Tonge, R., Blinco, D., Pierce, A. et al., Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 2004, 103, 3751-3759.
35. Kim, D. R., Proteomic changes during the B cell development. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 815, 295-303.
36. Boraldi, F., Bini, L., Liberatori, S., Armini, A. et al., Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages. Proteomics 2003, 3, 917-929.
37. Park, Y. D., Kim, S. Y., Jang, H. S., Seo, E. Y. et al., Towards a proteomic analysis of atopic dermatitis: A two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics 2004, 4, 3446-3455.
38. Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M. et al., Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308, 1472-1477.
39. Delany, J. P., Floyd, Z. E., Zvonic, S., Smith, A. et al., Proteomic analysis of primary cultures of human adipose-derived stem cells: Modulation by adipogenesis. Mol. Cell. Proteomics 2005, 4, 731-740.
40. Kim, S. I., Voshol, H., van Oostrum, J., Hastings, T. G. et al., Neuroproteomics: Expression profiling of the brain's proteomes in health and disease. Neurochem. Res. 2004, 29, 1317-1331.
41. Maisel, M., Herr, A., Milosevic, J., Hermann, A. et al., Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells 2007, 25, 1231-1240.
42. Maurer, M. H., Bromme, J. O., Feldmann, R. E., Jr., Jarve, A. et al., Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone. J. Proteome. Res. 2007, 6, 1198-1208.
43. Hirsch, C., Campano, L. M., Wohrle, S., Hecht, A., Canonical Wnt signaling transiently stimulates proliferation and enhances neurogenesis in neonatal neural progenitor cultures. Exp. Cell Res. 2007, 313, 572-587.
44. Lie, D. C., Colamarino, S. A., Song, H. J., Desire, L. et al., Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437, 1370-1375.
45. Choi, C. B., Cho, Y. K., Prakash, K. V., Jee, B. K. et al., Analysis of neuron-like differentiation of human bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2006, 350, 138-146.
46. Cattaneo, E., Conti, L., Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J. Neurosci. Res. 1996, 53, 223-234.
47. Pahnke, J., Mix, E., Knoblich, R., Muller, J. et al., Over-expression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells. Exp. Cell Res. 2004, 297, 484-494.
48. Skalnikova, H., Halada, P., Vodicka, P., Motlik, J. et al., A proteomic approach to studying the differentiation of neural stem cells. Proteomics 2007, 7, 1825-1838.
49. Pearce, A., Svendsen, C. N., Characterisation of stem cell expression using two-dimensional electrophoresis. Electrophoresis 1999, 20, 969-970.
50. Miyachi, K., Fritzler, M. J., Tan, E. M., Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 1976, 121, 2228-2234.
51. Takasaki, Y., Fishwild, D., Tan, E. M., Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J. Exp. Med. 1984, 59, 981-992.
52. Iatropoulos, M. J., Williams, G. M., Proliferation markers. Exp. Toxicol. Pathol. 1996, 48, 175-181.
53. Butterfield, L. H., Merino, A., Golub, S. H., Shau, H., From cytoprotection to tumor suppression: The multifactorial role of peroxiredoxins. Antioxid. Redox Signal. 1999, 1, 385-402.
54. Fujii, J., Ikeda, Y., Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox. Rep. 2002, 7, 123-130.
55. Hirotsu, S., Abe, Y., Okada, K., Nagahara, N. et al., Crystal structure of a multifunctional 2-Cys peroxiredoxin hemebinding protein 23 kDa/proliferation-associated gene product. Proc. Natl. Acad. Sci. USA 1999, 96, 12333-12338.
56. Kim, S. H., Fountoulakis, M., Cairns, N., Lubec, G., Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neural Transm. Suppl. 2001, 61, 223-235.
57. Solway, J., Seltzer, J., Samaha, F. F., Kim, S. et al., Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J. Biol. Chem. 1995, 270, 13460-13469.
58. Lawson, D., Harrison, M., Shapland, C., Fibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil. Cytoskeleton 1997, 38, 250-257.
59. Duband, J. L., Gimona, M., Scatena, M., Sartore, S. et al., Calponin and SM 22 as differentiation markers of smooth muscle: Spatiotemporal distribution during avian embryonic development. Differentiation 1993, 55, 1-11.
60. Böttcher, T., Mix, E., Koczan, D., Bauer, P. et al., Gene expression profiling of ciliary neurotrophic factor-over-expressing rat striatal progenitor cells (ST14A) indicates improved stress response during the early stage of differentiation. J. Neurosci. Res. 2003, 73, 42-53.
61. Gurok, U., Steinhoff, C., Lipkowitz, B., Ropers, H. H. et al., Gene expression changes in the course of neural progenitor cell differentiation. J. Neurosci. 2004, 24, 5982-6002.
62. Volker, U., Hecker, M., From genomics via proteomics to cellular physiology of the Gram-positive model organism Bacillus subtilis. Cell Microbiol. 2005, 7, 1077-1085.
63. Unwin, R. D., Whetton, A. D., Systematic proteome and transcriptome analysis of stem cell populations. Cell Cycle 2006, 5, 1587-1591.
64. Wagner, W., Feldmann, R. E., Jr., Seckinger, A., Maurer, M. H. et al., The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp. Hematol. 2006, 34, 536-548.
65. Garbis, S., Lubec, G., Fountoulakis, M., Limitations of current proteomics technologies. J. Chromatogr. A 2005, 1077, 1-18.
66. Fountoulakis, M., Application of proteomics technologies in the investigation of the brain. Mass Spectrom. Rev. 2004, 23, 231-258.
67. Huber, L. A., Is proteomics heading in the wrong direction? Nat. Rev. Mol. Cell Biol. 2003, 4, 74-80.
68. Canas, B., Lopez-Ferrer, D., Ramos-Fernandez, A., Camafeita, E. et al., Mass spectrometry technologies for proteomics. Brief Funct. Genomic. Proteomic. 2006, 4, 295-320.
69. Thongboonkerd, V., Proteomics in nephrology: Current status and future directions. Am. J. Nephrol. 2004, 24, 360-378.
70. Boettcher, T., Mix, E., Koczan, D., Bauer, P. et al., Gene expression profiling of ciliary neurotrophic factor-over-expressing rat striatal progenitor cells (ST14A) indicates improved stress response during the early stage of differentiation. J. Neurosci. Res. 2003, 73, 42-53.
71. Wei, C. L., Miura, T., Robson, P., Lim, S. K. et al., Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells 2005, 23, 166-185.
72. Unwin, R. D., Gaskell, S. J., Evans, C. A., Whetton, A. D., The potential for proteomic definition of stem cell populations. Exp. Hematol. 2003, 31, 1147-1159.
73. Lange, C., Mix, E., Rateitschak, K., Rolfs, A., Wnt signal pathways and neural stem cell differentiation. Neurodegener. Dis. 2006, 3, 76-86.
74. Hoffrogge, R., Mikschofsky, H., Piechulla, B., Surface plasmon resonance spectroscopy (SPR) interaction studies of the circadian-controlled tomato LHCa4*1 (CAB 11) protein with its promoter. Chronobiol. Int. 2003, 20, 543-558.
75. Stelzl, U., Worm, U., Lalowski, M., Haenig, C. et al., A human protein-protein interaction network: A resource for annotating the proteome. Cell 2005, 122, 957-968.
76. Eyckerman, S., Lemmens, I., Catteeuw, D., Verhee, A. et al., Reverse MAPPIT: Screening for protein-protein interaction modifiers in mammalian cells. Nat. Methods 2005, 2, 427-433.
77. Schubert, W., Bonnekoh, B., Pommer, A. J., Philipsen, L. et al., Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat. Biotechnol. 2006, 24, 1270-1278.